AbbVie Inc.
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Total Cash from Operations: $19.03B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.20B | 6.3% |
| Business Acquisitions | $201.6M | 1.1% |
| Other Investing | $5.05B | 26.5% |
| Dividends Paid | $7.85B | 41.2% |
| Stock Repurchases | $659.8M | 3.5% |
| Other | $4.07B | 21.4% |
| Net Cash Flow | $0 | 0.0% |